1,880 Shares in HCA Healthcare, Inc. $HCA Acquired by Havemeyer Place LP

Havemeyer Place LP bought a new position in shares of HCA Healthcare, Inc. (NYSE:HCA) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund bought 1,880 shares of the company’s stock, valued at approximately $878,000.

Several other institutional investors have also added to or reduced their stakes in the company. 111 Capital boosted its stake in HCA Healthcare by 67.0% in the 4th quarter. 111 Capital now owns 1,468 shares of the company’s stock valued at $685,000 after purchasing an additional 589 shares during the period. Vestcor Inc boosted its stake in HCA Healthcare by 15.2% in the 4th quarter. Vestcor Inc now owns 26,268 shares of the company’s stock valued at $12,263,000 after purchasing an additional 3,473 shares during the period. MCF Advisors LLC lifted its position in shares of HCA Healthcare by 213.0% during the 4th quarter. MCF Advisors LLC now owns 72 shares of the company’s stock valued at $34,000 after acquiring an additional 49 shares during the period. First Command Advisory Services Inc. bought a new stake in shares of HCA Healthcare during the 4th quarter valued at $49,000. Finally, Pinebridge Investments LLC bought a new stake in shares of HCA Healthcare during the 4th quarter valued at $37,910,000. 62.73% of the stock is currently owned by institutional investors.

HCA Healthcare Stock Down 3.0%

Shares of HCA opened at $360.99 on Tuesday. The stock has a market cap of $80.08 billion, a PE ratio of 12.41, a PEG ratio of 1.18 and a beta of 1.12. The business has a 50-day simple moving average of $437.12 and a two-hundred day simple moving average of $476.37. HCA Healthcare, Inc. has a 12-month low of $330.00 and a 12-month high of $556.52.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Friday, April 24th. The company reported $7.15 earnings per share for the quarter, missing the consensus estimate of $7.19 by ($0.04). The company had revenue of $19.11 billion during the quarter, compared to analyst estimates of $19.09 billion. HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. The company’s quarterly revenue was up 4.3% on a year-over-year basis. During the same period in the previous year, the company posted $6.45 EPS. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. On average, equities research analysts expect that HCA Healthcare, Inc. will post 30.07 EPS for the current year.

HCA Healthcare Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, June 30th. Stockholders of record on Tuesday, June 16th will be paid a $0.78 dividend. The ex-dividend date of this dividend is Tuesday, June 16th. This represents a $3.12 annualized dividend and a dividend yield of 0.9%. HCA Healthcare’s dividend payout ratio is presently 10.73%.

Wall Street Analysts Forecast Growth

A number of research firms have recently weighed in on HCA. Weiss Ratings downgraded HCA Healthcare from a “buy (b)” rating to a “buy (b-)” rating in a research report on Monday, May 18th. Wells Fargo & Company dropped their price objective on HCA Healthcare from $481.00 to $436.00 and set an “equal weight” rating for the company in a research report on Monday, April 27th. Royal Bank Of Canada dropped their price objective on HCA Healthcare from $593.00 to $534.00 and set an “outperform” rating for the company in a research report on Monday, April 27th. UBS Group upped their price objective on HCA Healthcare from $598.00 to $635.00 and gave the stock a “buy” rating in a research report on Monday, February 23rd. Finally, KeyCorp dropped their price objective on HCA Healthcare from $550.00 to $510.00 and set an “overweight” rating for the company in a research report on Monday, April 27th. Sixteen equities research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, HCA Healthcare presently has a consensus rating of “Moderate Buy” and a consensus target price of $506.14.

HCA Healthcare Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.